Higher levels of TML were associated with male gender, and an overall more adverse CVD risk profile, including more often established coronary and cerebrovascular disease, hypertension, diabetes and higher serum creatinine, hs-CRP and neopterin, as well as usage of betablockers, statins, ACE inhibitors and angiotensin II receptor blockers. This evidence concerns the gene ACE and Hypertension.